Frovatriptan -: Antimigraine 5-HT1B/1D agonist

被引：0

作者：

不详

机构：

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：705 / 706

页数：2

相关论文

共 11 条

[1]

CADY R, 2001, CEPHALALGIA, V21

[2] Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs [J].

Carel, I ;

Ghaleh, B ;

Edouard, A ;

Dubois-Rande, JL ;

Parsons, AA ;

Giudicelli, JF ;

Berdeaux, A .

BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (05) :1071-1083

[3]

GERAUD G, 2000, CEPHALALGIA, V20

[4]

GERAUD G, 2001, CEPHALALGIA, V21

[5]

KEYWOOD C, 2001, CEPHALALGIA, V21

[6] Development of an analytical methodology from toxicokinetic to clinical studies for the anti-migraine drug frovatriptan [J].

Laugher, L ;

Briggs, R ;

Doughty, J ;

Noctor, TAG .

CHROMATOGRAPHIA, 2000, 52 (Suppl 1) :S113-S119

[7]

MACGREGOR EA, 2000, CEPHALALGIA, V20

[8]

MCAGREGOR EA, 2000, CEPHALALGIA, V20

[9]

PORTER RH, 2001, CEPHALALGIA, V21

[10]

SPIERINGS ELH, 2000, CEPHALALGIA, V20